Basic Science Research Grants

Grant Title : Leukocyte Chemokine Blockade to Preserve Lung Development
Funding Source: (NIH-5R501 HL067021-04)
Principal Investigator: Richard Auten, M.D.

Grant Title : Oxidative stress and inflammation impaired postnatal lung development
Funding Source: (NIH HL-067021)
Principal Investigator: Richard Auten, M.D.

Grant Title : Bronchopulmonary dysplasia drug therapy
Funding Source: (HL- 072614)
Principal Investigator: Dean Maeda Ph.D
 Co-Investigator: Richard Auten, M.D.

Grant Title : S-nitrosothiol regulation of postnatal lung development
Funding Source: (Nitrox, LLC)
Principal Investigator: Richard Auten, M.D.

Grant Title : Pre- and post-natal multiple air pollutant exposure and abnormal airway development
Funding Source: (Environmental Protection Agency)
Principal Investigator: Richard Auten, M.D.

Grant Title : Mechanisms of Auto-Rhythmicity in Heart Development
Funding Source: (NIH RO1 HL071015-04)
Principal Investigator: Tony Creazzo, Ph.D.

Grant Title : Development of the Heart: Role of Neural Crest
Funding Source: (NIH PO1 HL-36059-18)
Principal Investigator: Margaret Kirby, Ph.D.

Grant Title : Characterization of Secondary Heart Field
Funding Source: (NIH 5R01HL070140-03)
Principal Investigator: Margaret Kirby, Ph.D.

Grant Title : Neural Crest Modulates FGF Signaling in the Pharynx
Funding Source: (NIH 3R01HL083240-01A1S1)
Principal Investigator: Margaret Kirby, Ph.D.

Grant Title : Modeling Conotruncal Malformations in Zebrafish Embryos
Funding Source: (1R01HL084413-01)
Principal Investigator: Margaret Kirby, Ph.D.

Grant Title : Molecular Genetics of Neural Tube Defects in Mouse Transgenic Models
Funding Source: ()
Principal Investigator: J. Klingensmith, Ph.D.

Basic Science Fellowship Reseach Projects:

 

 

Clinical Research Grants

Grant Title : Cooperative Multicenter Neonatal Research Network
Funding Source: (NIH RFA 5U10-HD40492)
Principal Investigator: Ronald Goldberg, MD

Current Projects:

 

Industry Grants

Grant Title : A Multicenter, Randomized, Open label, Single AND Multiple Dose Study Of The Pharmacokinetics And Pharmacodynamic Of 2 Dose Levels Of Pantoprazole Sodium enteric-coated Spheroid Suspension In Infants Aged 1 Through 11 Months With Presumed GERD
Funding Source: Clinical Industry Trial [3001B3-333-US]
Principal Investigator: C. Michael Cotten, M.D.

Grant Title : A Multicenter, Open-Label Pharmacokinetic, Pharmacodynamic, and Safety Study of Pantoprazole for Injection in Neonates and Preterm Infants with a Clinical Diagnosis of Gastroesophageal
Reflux Disease (GERD)
Funding Source: Clinical Industry Trial [PROTOCOL NO. 3001K3-331]
Principal Investigator: C. Michael Cotten, M.D.

Grant Title : A Prospective, Non-Interventional Study to Evaluate the Incidence
of Hospitalizations and Medically-Attended Lower Respiratory Tract Infection (MALR) in Premature Infants 32 to 35 Weeks Gestational Age Who Are Not Recommended to Receive Prophylaxis for RSV
Funding Source: Clinical Industry Trial
Principal Investigator: C. Michael Cotten, M.D.

Grant Title : Diagnosis of Gastro-esophageal Reflux Disease in Very Low Birthweight Infants
Funding Source: Clinical Industry Trial (Gerber Grant)
Principal Investigator: William F Malcolm, M.D.

Grant Title : Treatment of Gastro-esophageal Reflux Disease in Very Low Birthweight Infants
Funding Source: Clinical Industry Trial (Gerber Grant)
Principal Investigator: William F Malcolm, M.D.


Pediatric Pharmacokinetics Research

Grant Title : Pharmacokinetics of Antimicrobials in Premature Infants
Funding Source: Pediatric Pharmacokinetics Research Network
Principal Investigator: C. Michael Cotten, M.D.

Grant Title : Dose-Ranging, safety and efficacy of Cathflo® Activase (Alteplase)T for the treatment of central catheter occlusion in neonates and infants; Phase I
Funding Source: Pediatric Pharmacokinetics Research Network
Principal Investigator: C. Michael Cotten, M.D.

Grant Title : A Multicenter, Open Label Pharmacokinetic Study of
Fluconazole in Infants.
Funding Source: Pediatric Pharmacokinetics Research Network
Principal Investigator: C. Michael Cotten, M.D.

Grant Title :An Open Label Study to Further Describe the Pharmacokinetics
of Micafungin in Neonates.
Funding Source: Astellas & Duke PI intiated
Principal Investigator: P. Brian Smith , M.D.

Grant Title : A Phase 1, Open Label Study to Further Describe the Pharmacokinetics of Micafungin in Neonates.
Funding Source: Astellas & Duke PI intiated
Principal Investigator: P. Brian Smith , M.D.

Grant Title : A Phase 3, Randomized, Double-Blind, Multi-Center Study To Compare the Efficacy and Safety of Micafungin versus Amphotericin B Deoxycholate for the Treatment of Neonatal Candidiasis.
Funding Source: Astellas & Duke PI intiated
Principal Investigator: P. Brian Smith , M.D.


Medical Informatics Grants

Grant Title : Automated Adverse Drug Event Detection and Intervention
Funding Source: AHRQ (5UC1HS014882-03)
Principal Investigator: Jeffrey M. Ferranti, M.D, M.S.
Grant Title : ISO-11179 Based Meta-Data Standard for Use in the Codified Exchange of Clinical Research Data
Funding Source: Neonatal Perinatal Research Institute (NPRI)
Principal Investigator: Jeffrey M. Ferranti, M.D, M.S.

 

T32 Fellowship Training Grant

Grant Title : Multidisciplinary Neonatal Training Grant
Funding Source: (NIH 1 T32 HD043728-01A2)
Principal Investigator: Ronald Goldberg, M.D

Current Projects:

Recent Projects:

Nursing Research Grants

Grant Title : Preterm Infants: Light Effects on Health and Development
Funding Source: NIH-R01 NR08044-01A
Principal Investigator: Debra Brandon RN, Ph.D.











 

 

{Heading}